Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of valproate-induced hyperammonemia in normal subjects by lipid ingestion.

J M Warter, C Marescaux, E Hirsch

    Journal of the Neurological Sciences
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Unexpected combination of inherited chorea-acanthocytosis with MDR3 (ABCB4) defect mimicking Wilson's disease.

    Clinical genetics·2010
    Same author

    Familial cortical myoclonic tremor with epilepsy: the third locus (FCMTE3) maps to 5p.

    Neurology·2010
    Same author

    Modulation of mu opioid receptor desensitization in peripheral sensory neurons by phosphoinositide 3-kinase gamma.

    Neuroscience·2010
    Same author

    A method for producing experimental venous thrombosis.

    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·2010
    Same author

    Heparin in the treatment of thromboembolic disease.

    Journal of the American Medical Association·2010
    Same author

    [Dynamics of the functional status of autonomic nervous system in rats under combined radiation/thermal injury in case of an open burn wound and wound covered by the polymer film].

    Radiatsionnaia biologiia, radioecologiia·2010
    Same journal

    Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

    Journal of the neurological sciences·2026
    Same journal

    Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

    Journal of the neurological sciences·2026
    Same journal

    Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

    Journal of the neurological sciences·2026
    Same journal

    Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

    Journal of the neurological sciences·2026
    Same journal

    Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

    Journal of the neurological sciences·2026
    Same journal

    Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

    Journal of the neurological sciences·2026
    See all related articles

    Sodium valproate (VPA) causes kidney-related hyperammonemia in fasting individuals. Medium-chain fatty acids can prevent and treat this VPA complication, increasing VPA

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Nephrology

    Background:

    • Sodium valproate (VPA), a branched short-chain fatty acid, is known to induce hyperammonemia.
    • This VPA-induced hyperammonemia is typically of renal origin, particularly in fasting states.
    • Hyperammonemia can lead to serious complications, including stuporous states, during VPA medication.

    Purpose of the Study:

    • To investigate the effect of medium-length, straight-chain fatty acids on VPA-induced hyperammonemia.
    • To determine if fatty acids can mitigate or prevent hyperammonemia associated with VPA treatment.
    • To explore the potential of fatty acids in managing VPA-related neurological complications.

    Main Methods:

    • Administration of sodium valproate (VPA) to fasting subjects.

    Related Experiment Videos

  • Concurrent administration of medium-length, straight-chain fatty acids.
  • Monitoring of ammonia levels and VPA free fraction in circulation.

    • Main Results:

    • Intake of medium-length, straight-chain fatty acids effectively abolished VPA-induced hyperammonemia.
    • A concomitant increase in the VPA free fraction was observed.
    • This suggests a mechanism involving altered VPA metabolism or distribution.

    Conclusions:

    • Medium-chain fatty acids demonstrate a therapeutic potential against VPA-induced hyperammonemia.
    • Fatty acids may serve as a preventative or treatment strategy for hyperammonemia complications in VPA therapy.
    • Further research into the mechanism and clinical application is warranted.